Anti-Angiogenic RNAi-Based Treatment of Endometriosis in a Rat Model Using CXCR4-Targeted Peptide Nanoparticles.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Anti-Angiogenic RNAi-Based Treatment of Endometriosis in a Rat Model Using CXCR4-Targeted Peptide Nanoparticles.
- Published In:
- International journal of molecular sciences, 26(21) (2025)
- Database ID:
- RPEP-10815
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-10815APA
Egorova, Anna; Freund, Svetlana; Krylova, Iuliia; Kislova, Anastasia; Kiselev, Anton. (2025). Anti-Angiogenic RNAi-Based Treatment of Endometriosis in a Rat Model Using CXCR4-Targeted Peptide Nanoparticles.. International journal of molecular sciences, 26(21). https://doi.org/10.3390/ijms262110582
MLA
Egorova, Anna, et al. "Anti-Angiogenic RNAi-Based Treatment of Endometriosis in a Rat Model Using CXCR4-Targeted Peptide Nanoparticles.." International journal of molecular sciences, 2025. https://doi.org/10.3390/ijms262110582
RethinkPeptides
RethinkPeptides Research Database. "Anti-Angiogenic RNAi-Based Treatment of Endometriosis in a R..." RPEP-10815. Retrieved from https://rethinkpeptides.com/research/egorova-2025-antiangiogenic-rnaibased-treatment-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.